Q2 2022 13F Holders as of 30 Jun 2022
-
Type / Class
-
Equity / COM NEW
-
Total 13F shares
-
9,870,332
-
Share change
-
+753,670
-
Total reported value
-
$19,740,000
-
Put/Call ratio
-
38%
-
Price per share
-
$2.00
-
Number of holders
-
29
-
Value change
-
+$1,422,402
-
Number of buys
-
7
-
Number of sells
-
13
Institutional Holders of TRACON PHARMACEUTICALS INC - COM NEW (TCON) as of Q2 2022
As of 30 Jun 2022,
TRACON PHARMACEUTICALS INC - COM NEW (TCON) was held by
29 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
9,870,332 shares.
The largest 10 holders included
Opaleye Management Inc., Ikarian Capital, LLC, VANGUARD GROUP INC, Linden Advisors LP, NEA Management Company, LLC, BlackRock Inc., BOOTHBAY FUND MANAGEMENT, LLC, TWO SIGMA ADVISERS, LP, GEODE CAPITAL MANAGEMENT, LLC, and Telemetry Investments, L.L.C..
This page lists
29
institutional shareholders reporting positions in this security
for the Q2 2022 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.